# PACLITAXEL
> **NDA216338** · New Drug Application · Sponsor: TEVA PHARMS INC · Approved 2023-05-11
## Drug
- **FDA Application Number:** NDA216338
- **Application type:** New Drug Application
- **Brand name:** PACLITAXEL
- **Generic name:** PACLITAXEL
- **Active ingredients:** PACLITAXEL
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2023-05-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216338)
---
*MORVS · CC0 1.0*